TAILORx: New data on cohort with recurrence score 26-100 shows 93% cancer-free rate at 5 years
A new analysis from TAILORx, the largest ever breast cancer treatment trial, is published today in JAMA Oncology. It reveals the clinical outcomes with chemotherapy in a subset of 1,389 women with a high Recurrence Score ...
Sep 30, 2019
0
3